Will tumor-agnostic drug development help accelerate precision medicine approaches?
The first accelerated approval for a tumor-agnostic drug was granted by the FDA...
Trending:
-
![]()
Emulate and AstraZeneca announce Organs-on-Chips partnership
-
![]()
LIDDS verifies NanoZolid for controlled release of cancer drugs
-
![]()
Merck’s Keytruda combo could be a winner for NSCLC and other solid tumours
-
![]()
ECCMID 2018: Ribaxamase demonstrates protection of the microbiome following Ceftriaxone treatment
-
![]()
Algorithm optimises peptides to target drug-resistant bacteria
-
![]()
Computer simulation offers digital penicillin production
Most Read
Company A-Z
Latest Content
Human and Animal Tissue Procurement
Caltag Medsystems has established agreements to procure both human and animal tissues.
Put it to the Test – Q&A with Charles Ischi
Charles Ischi answers questions about the process of selecting testing equipment for oral solid dose applications.
Oncology Drug Testing Service
Noble’s scientists have been implementing effective and efficient approaches to help its customers achieve success for more than 30 years.
Validated Metal Analysis
Four commonly utilized carbohydrates for ptotein stabilization are Sucrose, Trehalose, Mannitol, and Maltose.
In Line With The Future – Charles Ischi Product Catalogue
Charles Ischi showcases its tablet and testing technology in research and production: LAB.line, IPC.line, and accessories.
B&W Tek’s New Website for Transmission Raman Spectroscopy
B&W Tek is proud to announce the launch of contentuniformity.com, a fully comprehensive website on the QTRam® and the benefits of transmission Raman spectroscopy.
IKA Laboratory Equipment Brochure
IKA helps your work be smarter, safer, and future-orientated, providing innovative solutions and products.
Getting Acquainted with the Theory of XRF
This white paper provides a general introduction to X-ray Fluorescence (CRF) spectrometry and XRF analysis. It explains how a spectrometer works and how XRF analysis is achieved.
Paradigm Shift Regarding API and Formulation Components
This whitepaper will provide an introduction to high-purity carbohydrates often used for applications such as stabilisation, modulation, and cryopreservation, comparing the old paradigm that formulation components are inactive ingredients with limited functionality with the new paradigm, which suggests these components play a significant role in therapeutic stability, quality, potency, immunogenicity, and bioavailability.
Adcetris® for the Treatment of Relapsed or Refractory Hodgkin’s Lymphoma
Adcetris® (brentuximab vedotin) is a treatment for relapsed or refractory (r/r) Hodgkin’s lymphoma (HL) and anaplastic large cell lymphoma (ALCL) that was developed by Seattle Genetics and Millennium Pharmaceuticals, a wholly owned subsidiary of Takeda Pharmaceutical.
Latest News
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Go Top
